Rapid and Real-Time Detection of Chikungunya Virus by Reverse Transcription Loop-Mediated Isothermal Amplification Assay

The standardization and validation of a one-step, single-tube, accelerated, quantitative reverse transcription (RT) loop-mediated isothermal amplification (RT-LAMP) assay targeting the E1 gene for the rapid and real-time detection of Chikungunya virus (CHIKV) are reported. A linear relationship betw...

Full description

Saved in:
Bibliographic Details
Published inJournal of Clinical Microbiology Vol. 45; no. 2; pp. 351 - 357
Main Authors Parida, M.M, Santhosh, S.R, Dash, P.K, Tripathi, N.K, Lakshmi, V, Mamidi, N, Shrivastva, A, Gupta, N, Saxena, P, Babu, J. Pradeep, Rao, P.V. Lakshmana, Morita, Kouichi
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.02.2007
Subjects
Online AccessGet full text
ISSN0095-1137
1098-660X
1098-5530
DOI10.1128/jcm.01734-06

Cover

Abstract The standardization and validation of a one-step, single-tube, accelerated, quantitative reverse transcription (RT) loop-mediated isothermal amplification (RT-LAMP) assay targeting the E1 gene for the rapid and real-time detection of Chikungunya virus (CHIKV) are reported. A linear relationship between the amount of template and time of positivity value over a range of 2 x 10⁸ to 2 x 10² copies was obtained. The feasibility of CHIKV RT-LAMP for clinical diagnosis was validated with patient serum samples from an ongoing epidemic in Southern India. Optimal assay conditions with zero background were established for the detection of low levels of CHIKV in acute-phase patient serum samples. The comparative evaluation of the RT-LAMP assay with acute-phase patient serum samples demonstrated exceptionally higher sensitivity by correctly identifying 21 additional positive borderline cases that were missed by conventional RT-PCR (P < 0.0001) with a detection limit of 20 copies. The quantification of virus load in patient serum samples was also determined from the standard curve based on their time of positivity and was found to be in the range of 2 x 10⁸ to 2 x 10¹ copies. In addition, the field applicability of the RT-LAMP assay was also demonstrated by standardizing SYBR Green I-based RT-LAMP wherein the amplification was carried out in a water bath at 63°C for 60 min, which was followed by monitoring gene amplification with the naked eye through color changes. These findings demonstrated that the RT-LAMP assay is a valuable tool for rapid, real-time detection as well as quantification of CHIKV in acute-phase serum samples without requiring any sophisticated equipment and has potential usefulness for clinical diagnosis and surveillance of CHIKV in developing countries.
AbstractList The standardization and validation of a one-step, single-tube, accelerated, quantitative reverse transcription (RT) loop-mediated isothermal amplification (RT-LAMP) assay targeting the E1 gene for the rapid and real-time detection of Chikungunya virus (CHIKV) are reported. A linear relationship between the amount of template and time of positivity value over a range of 2 x 10(8) to 2 x 10(2) copies was obtained. The feasibility of CHIKV RT-LAMP for clinical diagnosis was validated with patient serum samples from an ongoing epidemic in Southern India. Optimal assay conditions with zero background were established for the detection of low levels of CHIKV in acute-phase patient serum samples. The comparative evaluation of the RT-LAMP assay with acute-phase patient serum samples demonstrated exceptionally higher sensitivity by correctly identifying 21 additional positive borderline cases that were missed by conventional RT-PCR (P < 0.0001) with a detection limit of 20 copies. The quantification of virus load in patient serum samples was also determined from the standard curve based on their time of positivity and was found to be in the range of 2 x 10(8) to 2 x 10(1) copies. In addition, the field applicability of the RT-LAMP assay was also demonstrated by standardizing SYBR Green I-based RT-LAMP wherein the amplification was carried out in a water bath at 63 degrees C for 60 min, which was followed by monitoring gene amplification with the naked eye through color changes. These findings demonstrated that the RT-LAMP assay is a valuable tool for rapid, real-time detection as well as quantification of CHIKV in acute-phase serum samples without requiring any sophisticated equipment and has potential usefulness for clinical diagnosis and surveillance of CHIKV in developing countries.The standardization and validation of a one-step, single-tube, accelerated, quantitative reverse transcription (RT) loop-mediated isothermal amplification (RT-LAMP) assay targeting the E1 gene for the rapid and real-time detection of Chikungunya virus (CHIKV) are reported. A linear relationship between the amount of template and time of positivity value over a range of 2 x 10(8) to 2 x 10(2) copies was obtained. The feasibility of CHIKV RT-LAMP for clinical diagnosis was validated with patient serum samples from an ongoing epidemic in Southern India. Optimal assay conditions with zero background were established for the detection of low levels of CHIKV in acute-phase patient serum samples. The comparative evaluation of the RT-LAMP assay with acute-phase patient serum samples demonstrated exceptionally higher sensitivity by correctly identifying 21 additional positive borderline cases that were missed by conventional RT-PCR (P < 0.0001) with a detection limit of 20 copies. The quantification of virus load in patient serum samples was also determined from the standard curve based on their time of positivity and was found to be in the range of 2 x 10(8) to 2 x 10(1) copies. In addition, the field applicability of the RT-LAMP assay was also demonstrated by standardizing SYBR Green I-based RT-LAMP wherein the amplification was carried out in a water bath at 63 degrees C for 60 min, which was followed by monitoring gene amplification with the naked eye through color changes. These findings demonstrated that the RT-LAMP assay is a valuable tool for rapid, real-time detection as well as quantification of CHIKV in acute-phase serum samples without requiring any sophisticated equipment and has potential usefulness for clinical diagnosis and surveillance of CHIKV in developing countries.
The standardization and validation of a one-step, single-tube, accelerated, quantitative reverse transcription (RT) loop-mediated isothermal amplification (RT-LAMP) assay targeting the E1 gene for the rapid and real-time detection of Chikungunya virus (CHIKV) are reported. A linear relationship between the amount of template and time of positivity value over a range of 2 x 10 super(8) to 2 x 10 super(2) copies was obtained. The feasibility of CHIKV RT-LAMP for clinical diagnosis was validated with patient serum samples from an ongoing epidemic in Southern India. Optimal assay conditions with zero background were established for the detection of low levels of CHIKV in acute-phase patient serum samples. The comparative evaluation of the RT-LAMP assay with acute-phase patient serum samples demonstrated exceptionally higher sensitivity by correctly identifying 21 additional positive borderline cases that were missed by conventional RT-PCR (P < 0.0001) with a detection limit of 20 copies. The quantification of virus load in patient serum samples was also determined from the standard curve based on their time of positivity and was found to be in the range of 2 x 10 super(8) to 2 x 10 super(1) copies. In addition, the field applicability of the RT-LAMP assay was also demonstrated by standardizing SYBR Green I-based RT-LAMP wherein the amplification was carried out in a water bath at 63 degree C for 60 min, which was followed by monitoring gene amplification with the naked eye through color changes. These findings demonstrated that the RT-LAMP assay is a valuable tool for rapid, real-time detection as well as quantification of CHIKV in acute-phase serum samples without requiring any sophisticated equipment and has potential usefulness for clinical diagnosis and surveillance of CHIKV in developing countries.
The standardization and validation of a one-step, single-tube, accelerated, quantitative reverse transcription (RT) loop-mediated isothermal amplification (RT-LAMP) assay targeting the E1 gene for the rapid and real-time detection of Chikungunya virus (CHIKV) are reported. A linear relationship between the amount of template and time of positivity value over a range of 2 x 10¸ to 2 x 10² copies was obtained. The feasibility of CHIKV RT-LAMP for clinical diagnosis was validated with patient serum samples from an ongoing epidemic in Southern India. Optimal assay conditions with zero background were established for the detection of low levels of CHIKV in acute-phase patient serum samples. The comparative evaluation of the RT-LAMP assay with acute-phase patient serum samples demonstrated exceptionally higher sensitivity by correctly identifying 21 additional positive borderline cases that were missed by conventional RT-PCR (P < 0.0001) with a detection limit of 20 copies. The quantification of virus load in patient serum samples was also determined from the standard curve based on their time of positivity and was found to be in the range of 2 x 10¸ to 2 x 10¹ copies. In addition, the field applicability of the RT-LAMP assay was also demonstrated by standardizing SYBR Green I-based RT-LAMP wherein the amplification was carried out in a water bath at 63°C for 60 min, which was followed by monitoring gene amplification with the naked eye through color changes. These findings demonstrated that the RT-LAMP assay is a valuable tool for rapid, real-time detection as well as quantification of CHIKV in acute-phase serum samples without requiring any sophisticated equipment and has potential usefulness for clinical diagnosis and surveillance of CHIKV in developing countries.
The standardization and validation of a one-step, single-tube, accelerated, quantitative reverse transcription (RT) loop-mediated isothermal amplification (RT-LAMP) assay targeting the E1 gene for the rapid and real-time detection of Chikungunya virus (CHIKV) are reported. A linear relationship between the amount of template and time of positivity value over a range of 2 × 10 8 to 2 × 10 2 copies was obtained. The feasibility of CHIKV RT-LAMP for clinical diagnosis was validated with patient serum samples from an ongoing epidemic in Southern India. Optimal assay conditions with zero background were established for the detection of low levels of CHIKV in acute-phase patient serum samples. The comparative evaluation of the RT-LAMP assay with acute-phase patient serum samples demonstrated exceptionally higher sensitivity by correctly identifying 21 additional positive borderline cases that were missed by conventional RT-PCR ( P < 0.0001) with a detection limit of 20 copies. The quantification of virus load in patient serum samples was also determined from the standard curve based on their time of positivity and was found to be in the range of 2 × 10 8 to 2 × 10 1 copies. In addition, the field applicability of the RT-LAMP assay was also demonstrated by standardizing SYBR Green I-based RT-LAMP wherein the amplification was carried out in a water bath at 63°C for 60 min, which was followed by monitoring gene amplification with the naked eye through color changes. These findings demonstrated that the RT-LAMP assay is a valuable tool for rapid, real-time detection as well as quantification of CHIKV in acute-phase serum samples without requiring any sophisticated equipment and has potential usefulness for clinical diagnosis and surveillance of CHIKV in developing countries.
The standardization and validation of a one-step, single-tube, accelerated, quantitative reverse transcription (RT) loop-mediated isothermal amplification (RT-LAMP) assay targeting the E1 gene for the rapid and real-time detection of Chikungunya virus (CHIKV) are reported. A linear relationship between the amount of template and time of positivity value over a range of 2 x 10⁸ to 2 x 10² copies was obtained. The feasibility of CHIKV RT-LAMP for clinical diagnosis was validated with patient serum samples from an ongoing epidemic in Southern India. Optimal assay conditions with zero background were established for the detection of low levels of CHIKV in acute-phase patient serum samples. The comparative evaluation of the RT-LAMP assay with acute-phase patient serum samples demonstrated exceptionally higher sensitivity by correctly identifying 21 additional positive borderline cases that were missed by conventional RT-PCR (P < 0.0001) with a detection limit of 20 copies. The quantification of virus load in patient serum samples was also determined from the standard curve based on their time of positivity and was found to be in the range of 2 x 10⁸ to 2 x 10¹ copies. In addition, the field applicability of the RT-LAMP assay was also demonstrated by standardizing SYBR Green I-based RT-LAMP wherein the amplification was carried out in a water bath at 63°C for 60 min, which was followed by monitoring gene amplification with the naked eye through color changes. These findings demonstrated that the RT-LAMP assay is a valuable tool for rapid, real-time detection as well as quantification of CHIKV in acute-phase serum samples without requiring any sophisticated equipment and has potential usefulness for clinical diagnosis and surveillance of CHIKV in developing countries.
Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue JCM About JCM Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JCM RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0095-1137 Online ISSN: 1098-660X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JCM .asm.org, visit: JCM       
The standardization and validation of a one-step, single-tube, accelerated, quantitative reverse transcription (RT) loop-mediated isothermal amplification (RT-LAMP) assay targeting the E1 gene for the rapid and real-time detection of Chikungunya virus (CHIKV) are reported. A linear relationship between the amount of template and time of positivity value over a range of 2 x 10(8) to 2 x 10(2) copies was obtained. The feasibility of CHIKV RT-LAMP for clinical diagnosis was validated with patient serum samples from an ongoing epidemic in Southern India. Optimal assay conditions with zero background were established for the detection of low levels of CHIKV in acute-phase patient serum samples. The comparative evaluation of the RT-LAMP assay with acute-phase patient serum samples demonstrated exceptionally higher sensitivity by correctly identifying 21 additional positive borderline cases that were missed by conventional RT-PCR (P < 0.0001) with a detection limit of 20 copies. The quantification of virus load in patient serum samples was also determined from the standard curve based on their time of positivity and was found to be in the range of 2 x 10(8) to 2 x 10(1) copies. In addition, the field applicability of the RT-LAMP assay was also demonstrated by standardizing SYBR Green I-based RT-LAMP wherein the amplification was carried out in a water bath at 63 degrees C for 60 min, which was followed by monitoring gene amplification with the naked eye through color changes. These findings demonstrated that the RT-LAMP assay is a valuable tool for rapid, real-time detection as well as quantification of CHIKV in acute-phase serum samples without requiring any sophisticated equipment and has potential usefulness for clinical diagnosis and surveillance of CHIKV in developing countries.
Author Tripathi, N.K
Gupta, N
Parida, M.M
Santhosh, S.R
Lakshmi, V
Babu, J. Pradeep
Dash, P.K
Mamidi, N
Morita, Kouichi
Rao, P.V. Lakshmana
Saxena, P
Shrivastva, A
AuthorAffiliation Division of Virology, Defence Research and Development Establishment, Gwalior 474002 M. P., India, 1 Department of Microbiology, Nizam's Institute of Medical Sciences, Hyderabad 500 082 A. P., India, 2 Department of Virology, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan 3
AuthorAffiliation_xml – name: Division of Virology, Defence Research and Development Establishment, Gwalior 474002 M. P., India, 1 Department of Microbiology, Nizam's Institute of Medical Sciences, Hyderabad 500 082 A. P., India, 2 Department of Virology, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan 3
Author_xml – sequence: 1
  fullname: Parida, M.M
– sequence: 2
  fullname: Santhosh, S.R
– sequence: 3
  fullname: Dash, P.K
– sequence: 4
  fullname: Tripathi, N.K
– sequence: 5
  fullname: Lakshmi, V
– sequence: 6
  fullname: Mamidi, N
– sequence: 7
  fullname: Shrivastva, A
– sequence: 8
  fullname: Gupta, N
– sequence: 9
  fullname: Saxena, P
– sequence: 10
  fullname: Babu, J. Pradeep
– sequence: 11
  fullname: Rao, P.V. Lakshmana
– sequence: 12
  fullname: Morita, Kouichi
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18511182$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17135444$$D View this record in MEDLINE/PubMed
BookMark eNqF0s9v0zAUB_AIDbFucOMMvrATGf4d54JUlQFDnZBGh7hZr47TeiRxsJNB_3u8tjBAQjv54M97evb3HWUHne9slj0l-JQQql5dm_YUk4LxHMsH2YTgUuVS4i8H2QTjUuSEsOIwO4rxGmPCuRCPskNSECY455PsxyX0rkLQVejSQpMvXGvRGztYMzjfIV-j2dp9HbvV2G0AfXZhjGi5SfbGhmjRIkAXTXD9Vs-97_MLWzkYbIXOox_WNrTQoGnbN652BrZsGiNsHmcPa2iifbI_j7Ort2eL2ft8_vHd-Ww6z41Q5ZDXRGJrl1hxUlNT1EyVNRWFWQpYQm0pSMWMElRJK7iRIMAkYAxUoiiMIuw4e73r24_L1lbGdkOARvfBtRA22oPTf990bq1X_kYTRUvMcWpwsm8Q_LfRxkG3LhrbNNBZP0YtVVlIKst7IS-oJJiyeyEphRSc8ASf_Tn776F_xZfAiz2AaKCpUxrGxTunBCHpHcm93DkTfIzB1ncE69st0h9mF3q7RRrLxOk_3Lhhm136Idf8rwjtitZutf7ugtUQW522U3OhqWbiNovnO1KD17AKadSrTxQThnHB04sY-wms2uBc
CODEN JCMIDW
CitedBy_id crossref_primary_10_1016_j_jcv_2009_06_010
crossref_primary_10_1086_529444
crossref_primary_10_1089_vim_2011_0068
crossref_primary_10_1186_1743_422X_8_464
crossref_primary_10_1002_adem_202201174
crossref_primary_10_1128_JCM_02248_09
crossref_primary_10_1016_j_diagmicrobio_2023_116111
crossref_primary_10_1186_1743_422X_7_140
crossref_primary_10_1016_j_diagmicrobio_2013_06_018
crossref_primary_10_1007_s10544_017_0209_9
crossref_primary_10_1016_j_jmoldx_2010_11_003
crossref_primary_10_1007_s11033_023_09110_z
crossref_primary_10_1515_cclm_2013_0363
crossref_primary_10_1016_j_jviromet_2017_12_005
crossref_primary_10_1186_s41182_020_00274_z
crossref_primary_10_1007_s00604_021_04986_9
crossref_primary_10_11150_kansenshogakuzasshi_84_431
crossref_primary_10_3390_ijms24076411
crossref_primary_10_1016_j_jviromet_2024_115030
crossref_primary_10_1007_s00604_024_06688_4
crossref_primary_10_1007_s10068_012_0012_6
crossref_primary_10_3389_fmicb_2019_00418
crossref_primary_10_4103_0971_5916_234607
crossref_primary_10_3390_bios14120609
crossref_primary_10_1016_j_eimc_2013_07_011
crossref_primary_10_1586_eri_11_132
crossref_primary_10_1016_j_diagmicrobio_2009_06_017
crossref_primary_10_1371_journal_pone_0147962
crossref_primary_10_5812_jjm_8_4_2015_16811
crossref_primary_10_1128_JCM_00350_19
crossref_primary_10_1371_journal_pntd_0000530
crossref_primary_10_1016_j_jviromet_2014_10_005
crossref_primary_10_1111_j_1469_0691_2010_03216_x
crossref_primary_10_2478_V10133_010_0004_8
crossref_primary_10_1016_j_virusres_2017_01_021
crossref_primary_10_1016_j_jviromet_2009_03_006
crossref_primary_10_1186_1869_5760_3_35
crossref_primary_10_1021_acs_analchem_6b01632
crossref_primary_10_1186_s12879_018_3611_x
crossref_primary_10_3109_1354750X_2010_494200
crossref_primary_10_1007_s12161_013_9718_1
crossref_primary_10_1016_j_antiviral_2019_03_009
crossref_primary_10_1016_j_jviromet_2010_03_027
crossref_primary_10_1016_j_jmii_2013_05_003
crossref_primary_10_1016_j_chemosphere_2022_135645
crossref_primary_10_1038_srep44778
crossref_primary_10_1016_j_virusres_2008_02_004
crossref_primary_10_1373_clinchem_2007_086595
crossref_primary_10_1016_j_mset_2019_10_002
crossref_primary_10_51620_0869_2084_2021_66_9_558_564
crossref_primary_10_1080_14737159_2021_1924059
crossref_primary_10_3389_fcimb_2023_1134921
crossref_primary_10_3390_vaccines11061102
crossref_primary_10_1016_j_jviromet_2013_07_004
crossref_primary_10_1128_JCM_00930_11
crossref_primary_10_1016_j_ijid_2011_09_020
crossref_primary_10_1007_s40291_022_00631_0
crossref_primary_10_1038_s41598_017_03734_5
crossref_primary_10_1038_s41598_022_16048_y
crossref_primary_10_1371_journal_pone_0100531
crossref_primary_10_1002_jmv_27842
crossref_primary_10_1016_j_jviromet_2013_05_004
crossref_primary_10_1089_vbz_2014_1680
crossref_primary_10_1016_j_tim_2007_12_003
crossref_primary_10_2174_1874285802115010077
crossref_primary_10_1371_journal_pntd_0004953
crossref_primary_10_1371_journal_pone_0185340
crossref_primary_10_1007_s40011_011_0015_8
crossref_primary_10_1007_s12033_012_9533_8
crossref_primary_10_1007_s10156_009_0669_9
crossref_primary_10_2147_IDR_S347545
crossref_primary_10_1039_c3mb70304e
crossref_primary_10_1186_s11671_024_04075_9
crossref_primary_10_1016_j_jmoldx_2012_10_004
crossref_primary_10_1016_j_jviromet_2021_114407
crossref_primary_10_1128_JCM_01188_08
crossref_primary_10_3347_kjp_2016_54_2_239
crossref_primary_10_1002_jmv_23406
crossref_primary_10_1128_spectrum_00088_23
crossref_primary_10_1016_j_jviromet_2013_03_004
crossref_primary_10_1177_1040638711403427
crossref_primary_10_1016_S0140_6736_11_60281_X
crossref_primary_10_1517_17530059_2_10_1155
crossref_primary_10_1371_journal_pntd_0006448
crossref_primary_10_1016_j_jviromet_2010_03_006
crossref_primary_10_1016_j_jviromet_2014_03_005
crossref_primary_10_2217_17460794_3_2_179
crossref_primary_10_1007_s12038_008_0079_7
crossref_primary_10_1126_scitranslmed_aag0538
crossref_primary_10_1142_S2339547817300025
crossref_primary_10_4081_idr_2012_e5
crossref_primary_10_1016_j_actatropica_2013_12_016
crossref_primary_10_1371_journal_pntd_0007480
crossref_primary_10_1007_s40744_018_0121_7
crossref_primary_10_1016_j_virusres_2023_199292
crossref_primary_10_1089_fpd_2008_0084
crossref_primary_10_1080_09273948_2023_2260464
crossref_primary_10_1186_1476_072X_8_61
crossref_primary_10_1016_j_jviromet_2011_05_020
crossref_primary_10_1128_CVI_00154_14
crossref_primary_10_1128_mSystems_00771_20
crossref_primary_10_1016_j_jviromet_2008_10_023
crossref_primary_10_1080_17458080_2012_743684
crossref_primary_10_1016_j_jcv_2016_01_008
crossref_primary_10_1111_jvh_12931
crossref_primary_10_1155_2022_5390685
crossref_primary_10_2987_21_7033
crossref_primary_10_1007_s41207_017_0035_8
crossref_primary_10_21055_0370_1069_2020_2_22_30
crossref_primary_10_1038_s41598_020_68469_2
crossref_primary_10_2987_21_7047
crossref_primary_10_1016_j_ajo_2007_06_002
crossref_primary_10_1089_vbz_2021_0011
crossref_primary_10_1007_s00705_021_05243_3
crossref_primary_10_1016_j_ijid_2019_12_028
crossref_primary_10_1002_jmv_21494
crossref_primary_10_1371_journal_pntd_0007184
crossref_primary_10_1186_s12985_021_01642_9
crossref_primary_10_1007_s11882_017_0680_7
crossref_primary_10_1111_gtc_12797
crossref_primary_10_1016_j_cmi_2024_03_004
crossref_primary_10_1128_CVI_05288_11
crossref_primary_10_1002_rmv_593
crossref_primary_10_2217_fvl_2022_0136
crossref_primary_10_4236_aim_2022_127029
crossref_primary_10_1021_acs_analchem_5b04054
crossref_primary_10_1016_j_jcv_2014_08_032
crossref_primary_10_1016_j_jviromet_2012_11_020
crossref_primary_10_1007_s10156_012_0415_6
crossref_primary_10_1016_j_aca_2021_339338
crossref_primary_10_3390_biology9080182
crossref_primary_10_1089_vim_2014_0031
Cites_doi 10.1111/j.1348-0421.1994.tb01866.x
10.1002/jmv.20168
10.1128/JCM.42.5.1956-1961.2004
10.1006/bbrc.2001.5921
10.1093/nar/28.12.e63
10.1006/mcpr.2002.0415
10.1371/journal.pmed.0030263
10.1128/JCM.43.6.2895-2903.2005
10.1002/jmv.10085
10.1128/JCM.42.1.257-263.2004
10.4269/ajtmh.1975.24.527
10.1099/0022-1317-83-12-3075
10.1093/nar/30.6.1292
10.1016/0035-9203(86)90358-5
10.1016/S0255-0857(21)02403-8
10.1016/j.trstmh.2004.03.013
ContentType Journal Article
Copyright 2007 INIST-CNRS
Copyright © 2007, American Society for Microbiology 2007
Copyright_xml – notice: 2007 INIST-CNRS
– notice: Copyright © 2007, American Society for Microbiology 2007
DBID FBQ
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7U9
H94
7S9
L.6
7X8
5PM
DOI 10.1128/jcm.01734-06
DatabaseName AGRIS
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
AIDS and Cancer Research Abstracts
AGRICOLA
CrossRef



MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1098-660X
1098-5530
EndPage 357
ExternalDocumentID PMC1829040
17135444
18511182
10_1128_JCM_01734_06
jcm_45_2_351
US201300743543
Genre Evaluation Studies
Journal Article
GroupedDBID ---
.55
.GJ
0R~
18M
29K
2WC
39C
3O-
4.4
41~
53G
5GY
5RE
5VS
AAYOK
ABOCM
ABPPZ
ACGFO
ADBBV
AENEX
AEQTP
AFMIJ
AGCDD
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CS3
D-I
DIK
DU5
E3Z
EBS
EJD
F5P
FBQ
FRP
GX1
HF~
HYE
HZ~
H~9
KQ8
L7B
O9-
OHT
OK1
P2P
P6G
RHF
RHI
RNS
RPM
RSF
TR2
UCJ
VH1
W8F
WHG
WOQ
X7M
ZA5
ZCA
ZGI
ZXP
~KM
AAGFI
AAYXX
AGVNZ
CITATION
H13
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
PKN
YIF
7U9
H94
7S9
L.6
7X8
5PM
ID FETCH-LOGICAL-c589t-f160eeb0841f2c7f389f257cb5abafe2a683c85286e54c6a5ac9f2ccad577c813
ISSN 0095-1137
IngestDate Thu Aug 21 18:04:05 EDT 2025
Thu Sep 04 22:15:22 EDT 2025
Fri Sep 05 00:14:16 EDT 2025
Fri Sep 05 08:46:40 EDT 2025
Wed Feb 19 01:47:14 EST 2025
Mon Jul 21 09:11:35 EDT 2025
Thu Apr 24 23:01:44 EDT 2025
Tue Jul 01 02:12:34 EDT 2025
Wed May 18 15:27:42 EDT 2016
Wed Dec 27 19:21:28 EST 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Virus
Amplification
Microbiology
Transcription
Chikungunya virus
Togaviridae
Alphavirus
Detection
Real time
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c589t-f160eeb0841f2c7f389f257cb5abafe2a683c85286e54c6a5ac9f2ccad577c813
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
Corresponding author. Mailing address: Division of Virology, Defence R & D Establishment, Jhansi Road, Gwalior 474002 M. P., India. Phone: 91-751-2233495. Fax: 91-751-2351148. E-mail: paridamm@rediffmail.com.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/1829040
PMID 17135444
PQID 19565414
PQPubID 23462
PageCount 7
ParticipantIDs highwire_asm_jcm_45_2_351
pubmed_primary_17135444
proquest_miscellaneous_19565414
fao_agris_US201300743543
crossref_primary_10_1128_JCM_01734_06
proquest_miscellaneous_47261023
pascalfrancis_primary_18511182
crossref_citationtrail_10_1128_JCM_01734_06
pubmedcentral_primary_oai_pubmedcentral_nih_gov_1829040
proquest_miscellaneous_68976269
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2007-02-01
PublicationDateYYYYMMDD 2007-02-01
PublicationDate_xml – month: 02
  year: 2007
  text: 2007-02-01
  day: 01
PublicationDecade 2000
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationTitle Journal of Clinical Microbiology
PublicationTitleAlternate J Clin Microbiol
PublicationYear 2007
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
(e_1_3_2_19_2) 2001; 45
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
(e_1_3_2_12_2) 1996; 1
(e_1_3_2_14_2) 2001; 45
e_1_3_2_20_2
e_1_3_2_10_2
e_1_3_2_11_2
e_1_3_2_22_2
e_1_3_2_4_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_24_2
(e_1_3_2_23_2) 2000; 81
e_1_3_2_25_2
(e_1_3_2_5_2) 2002; 115
(e_1_3_2_21_2) 2006; 124
(e_1_3_2_7_2) 1988
(e_1_3_2_2_2) 1985
15332277 - J Med Virol. 2004 Oct;74(2):277-82
16700631 - PLoS Med. 2006 Jul;3(7):e263
10871386 - Nucleic Acids Res. 2000 Jun 15;28(12):E63
11884626 - Nucleic Acids Res. 2002 Mar 15;30(6):1292-305
12083330 - Acta Virol. 2001;45(5-6):305-9
1174020 - Am J Trop Med Hyg. 1975 May;24(3):527-32
12239836 - Indian J Med Res. 2002 Apr;115:144-8
16687855 - Indian J Med Microbiol. 2006 Apr;24(2):83-4
11708792 - Biochem Biophys Res Commun. 2001 Nov 23;289(1):150-4
12466484 - J Gen Virol. 2002 Dec;83(Pt 12):3075-84
15131154 - J Clin Microbiol. 2004 May;42(5):1956-61
10644846 - J Gen Virol. 2000 Feb;81(Pt 2):471-9
12083329 - Acta Virol. 2001;45(5-6):299-304
15956414 - J Clin Microbiol. 2005 Jun;43(6):2895-903
3026069 - Trans R Soc Trop Med Hyg. 1986;80(3):491
7869964 - Microbiol Immunol. 1994;38(10):827-30
14715762 - J Clin Microbiol. 2004 Jan;42(1):257-63
12144774 - Mol Cell Probes. 2002 Jun;16(3):223-9
15693148 - Trans R Soc Trop Med Hyg. 2005 Feb;99(2):128-41
15664052 - J Virol Methods. 2005 Mar;124(1-2):65-71
12116030 - J Med Virol. 2002 Jul;67(3):370-4
References_xml – ident: e_1_3_2_6_2
  doi: 10.1111/j.1348-0421.1994.tb01866.x
– volume: 124
  start-page: 65
  year: 2006
  ident: e_1_3_2_21_2
  publication-title: J. Virol. Methods
– ident: e_1_3_2_20_2
  doi: 10.1002/jmv.20168
– ident: e_1_3_2_4_2
  doi: 10.1128/JCM.42.5.1956-1961.2004
– start-page: 137
  year: 1988
  ident: e_1_3_2_7_2
  publication-title: The arboviruses: epidemiology and ecology
– ident: e_1_3_2_13_2
  doi: 10.1006/bbrc.2001.5921
– ident: e_1_3_2_16_2
  doi: 10.1093/nar/28.12.e63
– volume: 45
  start-page: 305
  year: 2001
  ident: e_1_3_2_14_2
  publication-title: Acta Virol.
– volume: 81
  start-page: 471
  year: 2000
  ident: e_1_3_2_23_2
  publication-title: J. Gen. Virol.
– ident: e_1_3_2_15_2
  doi: 10.1006/mcpr.2002.0415
– volume: 45
  start-page: 299
  year: 2001
  ident: e_1_3_2_19_2
  publication-title: Acta Virol.
– ident: e_1_3_2_25_2
  doi: 10.1371/journal.pmed.0030263
– volume: 1
  start-page: 843
  year: 1996
  ident: e_1_3_2_12_2
  publication-title: Fields virology
– start-page: 43
  year: 1985
  ident: e_1_3_2_2_2
  publication-title: Virology: a practical approach
– ident: e_1_3_2_17_2
  doi: 10.1128/JCM.43.6.2895-2903.2005
– ident: e_1_3_2_3_2
  doi: 10.1002/jmv.10085
– ident: e_1_3_2_18_2
  doi: 10.1128/JCM.42.1.257-263.2004
– volume: 115
  start-page: 44
  year: 2002
  ident: e_1_3_2_5_2
  publication-title: Indian J. Med. Res.
– ident: e_1_3_2_8_2
  doi: 10.4269/ajtmh.1975.24.527
– ident: e_1_3_2_9_2
  doi: 10.1099/0022-1317-83-12-3075
– ident: e_1_3_2_11_2
  doi: 10.1093/nar/30.6.1292
– ident: e_1_3_2_22_2
  doi: 10.1016/0035-9203(86)90358-5
– ident: e_1_3_2_24_2
  doi: 10.1016/S0255-0857(21)02403-8
– ident: e_1_3_2_10_2
  doi: 10.1016/j.trstmh.2004.03.013
– reference: 1174020 - Am J Trop Med Hyg. 1975 May;24(3):527-32
– reference: 10644846 - J Gen Virol. 2000 Feb;81(Pt 2):471-9
– reference: 15693148 - Trans R Soc Trop Med Hyg. 2005 Feb;99(2):128-41
– reference: 15131154 - J Clin Microbiol. 2004 May;42(5):1956-61
– reference: 14715762 - J Clin Microbiol. 2004 Jan;42(1):257-63
– reference: 11884626 - Nucleic Acids Res. 2002 Mar 15;30(6):1292-305
– reference: 11708792 - Biochem Biophys Res Commun. 2001 Nov 23;289(1):150-4
– reference: 15332277 - J Med Virol. 2004 Oct;74(2):277-82
– reference: 15664052 - J Virol Methods. 2005 Mar;124(1-2):65-71
– reference: 12083329 - Acta Virol. 2001;45(5-6):299-304
– reference: 12083330 - Acta Virol. 2001;45(5-6):305-9
– reference: 12239836 - Indian J Med Res. 2002 Apr;115:144-8
– reference: 10871386 - Nucleic Acids Res. 2000 Jun 15;28(12):E63
– reference: 12144774 - Mol Cell Probes. 2002 Jun;16(3):223-9
– reference: 3026069 - Trans R Soc Trop Med Hyg. 1986;80(3):491
– reference: 7869964 - Microbiol Immunol. 1994;38(10):827-30
– reference: 16700631 - PLoS Med. 2006 Jul;3(7):e263
– reference: 12116030 - J Med Virol. 2002 Jul;67(3):370-4
– reference: 12466484 - J Gen Virol. 2002 Dec;83(Pt 12):3075-84
– reference: 15956414 - J Clin Microbiol. 2005 Jun;43(6):2895-903
– reference: 16687855 - Indian J Med Microbiol. 2006 Apr;24(2):83-4
SSID ssj0014455
ssj0014452
Score 2.3038015
Snippet The standardization and validation of a one-step, single-tube, accelerated, quantitative reverse transcription (RT) loop-mediated isothermal amplification...
Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
highwire
fao
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 351
SubjectTerms Acute Disease
Alphavirus Infections - diagnosis
Alphavirus Infections - virology
Animals
Biological and medical sciences
Cell Line
Chikungunya virus
Chikungunya virus - genetics
Chikungunya virus - isolation & purification
Cricetinae
Fundamental and applied biological sciences. Psychology
Humans
Infectious diseases
Medical sciences
Microbiology
Miscellaneous
Nucleic Acid Amplification Techniques - methods
Reverse Transcriptase Polymerase Chain Reaction - methods
RNA, Viral - analysis
RNA, Viral - blood
RNA, Viral - isolation & purification
Sensitivity and Specificity
Time Factors
Virology
Title Rapid and Real-Time Detection of Chikungunya Virus by Reverse Transcription Loop-Mediated Isothermal Amplification Assay
URI http://jcm.asm.org/content/45/2/351.abstract
https://www.ncbi.nlm.nih.gov/pubmed/17135444
https://www.proquest.com/docview/19565414
https://www.proquest.com/docview/47261023
https://www.proquest.com/docview/68976269
https://pubmed.ncbi.nlm.nih.gov/PMC1829040
Volume 45
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEIgXBAO2cBl-gKcqoXHsxH1EFWgMOo1d0N4sx3VYYb1obSXGf-Q_cY5z31YESFVUpVaT6PtyfI59zncIeSV5pFOWGt-C4fP5KEr9fl9LP7ZpNgpFwkeZy_Ldj3dP-N6pOO10fjWyllbLNDA_b6wr-R9U4RzgilWy_4Bs9adwAr4DvnAEhOH4Vxgf6vl4VJQY6nMfyznAgCytKd3Awdn4O7zNq-ml7n4ZX6wW6G0eWkzFsLmueWU0Ps1mc3_oGneAD_ph4SqzJggg5pxnxdIewqlbO8ENj3ZQVlkOx7W8U4Vo0IXPAYTm9RrAUdA9DLpHGgUMFtW69EHQ_RgAHesz--7M8cXY9U9uLVQkZW5zSa1yB6qZjnrtfgoz3Rd-GOZqMIHNLTMKn8Zx77RpunMlyoKirGGHo1zF9vr8wLDmYW8wDMASRdx3agfLBlXmE8eVEDsX8lyZsi3SfWXyrFIav5mJ4kIxFWFB_22WgCuHOQKf600tzkXeUKN4urIOg8k3zTtCHdvi8i1n6VamZw0Za8zi1QsANcs7sNwUIl3N9G24TscPyP2CIfRtTuCHpGOnm-RO3gX1cpPcHRb5HY_ID8doCoymFaNpxWg6y2iD0dQxmqaXtGA0bTGathhNa0bTFqOpY_RjcvL-3fFg1y96g_hGyP7Sz8K4Z23akzzMmEky8LszmH1MKnSqM8t0LCMjBZOxFdzEWmgDA8BcjUSSGBlGT8jGdDa124SynjEjYSXrGwgO0lBjiwcdQmQjcQEn9Ui3BEGZQjgf-7ecKxdAM6kAPeXQU73YI6-r0fNcMGbNuG3AU-mvMJerkyOGGQTozgseecQrQVZ6MVFNanlkp4V6fQ0MnULJPPKypIGCmQK3__TUzlYLhZXBgod8_QiesBilXNaPiCWELyzue2QrJ1Z9_YKyHklalKsGoI59-5fp-Mzp2YeYzMF7T__w2M_IvdqkPCcby4uVfQHRwDLdce_Yb6p7C5A
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rapid+and+Real-Time+Detection+of+Chikungunya+Virus+by+Reverse+Transcription+Loop-Mediated+Isothermal+Amplification+Assay&rft.jtitle=Journal+of+Clinical+Microbiology&rft.au=M.+M.+Parida&rft.au=S.+R.+Santhosh&rft.au=P.+K.+Dash&rft.au=N.+K.+Tripathi&rft.date=2007-02-01&rft.pub=American+Society+for+Microbiology&rft.issn=0095-1137&rft.eissn=1098-660X&rft.volume=45&rft.issue=2&rft.spage=351&rft_id=info:doi/10.1128%2FJCM.01734-06&rft_id=info%3Apmid%2F17135444&rft.externalDBID=n%2Fa&rft.externalDocID=jcm_45_2_351
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0095-1137&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0095-1137&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0095-1137&client=summon